tert-Butyl (2-bromothiazol-4-yl)carbamate, 95.0%, 5g

3-(5-Bromothiophen-2-yl)-2,5-bis(2-ethylhexyl)-6-(thiophen-2-yl)pyrrolo[3,4-c]pyrrole-1,4(2H,5H)-dione, 98%, 250mg

(1-Bromo-propyl)-benzene, 95.0%, 250mg

6-(2-(Benzyloxy)ethoxy)hexan-1-ol, 95%, 1g

TERT-BUTYL 4-TERT-BUTOXY-3-NITROBENZOATE, 95.0%, 250mg

N-(1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide, 95.0%, 25g

Sodium 4-amino-2-hydroxybenzoate dihydrate, 98.0%, 250g

2-(BUT-3-EN-1-YL)ISOINDOLINE-1,3-DIONE, 95.0%, 10g

2,3,4,6-tetrafluoropyridine, 95.0%, 250mg

2,6-DIFLUORO-4-ISOPROPOXYPHENYLBORONIC ACID, 95.0%, 5g

2,3-Dichlorobenzenesulfonamide, 97.0%, 5g

GC capillary column ROTI®Cap-1, 15 m, 0.25 mm, 0.25 µm, 1 Piece(s)

2-methyltetrahydro-2H-pyrazino[1,2-a]pyrazine-1,4(3H,6H)-dione, 95.0%, 250mg